Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5726
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$46.1M
| $244K | ﹤0.01% |
2,061
+201
| +11% | +$21.5K |
2013 Q2
52 quarters
|
|
5727
iShares US Small Cap Value Factor ETF
SVAL
$157M
| $244K | ﹤0.01% |
5,845
| – | – |
2021 Q4
18 quarters
|
|
5728
Direxion HCM Tactical Enhanced US ETF
HCMT
$609M
| $244K | ﹤0.01% |
+5,821
| New | +$227K |
2026 Q2
0 quarters
|
|
5729
Watsco Inc Class B
WSO.B
| $243K | ﹤0.01% |
589
| – | – |
2013 Q4
50 quarters
|
|
5730
Alector
ALEC
$210M
| $242K | ﹤0.01% |
120,480
-244,087
| -67% | -$523K |
2019 Q1
29 quarters
|
|
5731
Glass House Brands
GLAS
$348M
| $242K | ﹤0.01% |
+18,587
| New | +$242K |
2026 Q2
0 quarters
|
|
5732
Seer Inc
SEER
$115M
| $241K | ﹤0.01% |
145,434
-15,445
| -10% | -$28K |
2020 Q4
22 quarters
|
|
5733
LuxExperience B.V.
LUXE
$1.3B
| $241K | ﹤0.01% |
32,415
-44,711
| -58% | -$357K |
2021 Q1
21 quarters
|
|
5734
Chegg
CHGG
$77.8M
| $241K | ﹤0.01% |
238,388
+48,589
| +26% | +$53.3K |
2013 Q4
50 quarters
|
|
5735
BNY Mellon Municipal Opportunities ETF
BMOP
$1.68B
| $239K | ﹤0.01% |
9,498
+1,055
| +12% | +$26.3K |
2026 Q1
1 quarter
|
|
5736
Dan IVES Wedbush AI Revolution ETF
IVES
$1.06B
| $239K | ﹤0.01% |
6,277
+2,210
| +54% | +$77.8K |
2025 Q4
2 quarters
|
|
5737
AN2 Therapeutics
ANTX
$134M
| $239K | ﹤0.01% |
49,379
-184,808
| -79% | -$795K |
2022 Q1
17 quarters
|
|
5738
Spruce Biosciences
SPRB
$112M
| $238K | ﹤0.01% |
4,411
+2,996
| +212% | +$167K |
2025 Q3
3 quarters
|
|
5739
Avantis Responsible International Equity ETF
AVSD
$360M
| $238K | ﹤0.01% |
2,974
-3
| -0.1% | -$237 |
2025 Q4
2 quarters
|
|
5740
SEALSQ Corp
LAES
$414M
| $236K | ﹤0.01% |
74,974
+21,178
| +39% | +$63.2K |
2024 Q4
6 quarters
|
|
5741
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.23B
| $235K | ﹤0.01% |
3,132
-2,900
| -48% | -$183K |
2013 Q2
52 quarters
|
|
5742
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$69.8M
| $234K | ﹤0.01% |
4,949
-2,118
| -30% | -$101K |
2019 Q3
27 quarters
|
|
5743
WhiteHawk Minerals Corp
WHK
$691M
| $234K | ﹤0.01% |
+8,407
| New | +$228K |
2026 Q2
0 quarters
|
|
5744
DoubleLine Commercial Real Estate Debt ETF
DCRE
$442M
| $233K | ﹤0.01% |
4,505
+1
| +0% | +$52 |
2025 Q2
4 quarters
|
|
5745
Trio-Tech International Common Stock
TRT
$53.2M
| $233K | ﹤0.01% |
18,906
+16,142
| +584% | +$184K |
2025 Q3
3 quarters
|
|
5746
State Street SPDR S&P 500 ESG ETF
EFIV
$1.01B
| $232K | ﹤0.01% |
3,177
-1
| -0% | -$70 |
2022 Q3
15 quarters
|
|
5747
Republic Airways Holdings
RJET
$738M
| $231K | ﹤0.01% |
11,017
+3,530
| +47% | +$68.9K |
2018 Q3
31 quarters
|
|
5748
Inhibikase Therapeutics
IKT
$251M
| $231K | ﹤0.01% |
114,006
-50,253
| -31% | -$89.9K |
2021 Q4
18 quarters
|
|
5749
BARK
BARK
$67.8M
| $230K | ﹤0.01% |
23,065
+11,395
| +98% | +$107K |
2020 Q4
22 quarters
|
|
5750
Schwab Mortgage-Backed Securities ETF
SMBS
$6.13B
| $230K | ﹤0.01% |
9,054
+6,830
| +307% | +$174K |
2025 Q2
4 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.